Taguiam, Nathalia Rechelle .
HRN: 25-41-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2024
CEFUROXIME 750MG (VIAL)
07/05/2024
07/11/2024
IVTT
750mg
Q8h
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes